Sporotrichosis: An update

Giornale Italiano di Dermatologia e Venereologia

Volumn 145, Issue 5, 2010, Pages 659-673

  Bonifaz, A ^a   Vazquez Gonzalez D ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Itraconazole; Mycosis; Potassium iodide; Sporotrichosis

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; COTRIMOXAZOLE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; POTASSIUM IODIDE; PREDNISONE; TERBINAFINE;

AGE DISTRIBUTION; ANGIONEUROTIC EDEMA; ANTIFUNGAL ACTIVITY; ARTICLE; BRONCHITIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DRUG INDUCED HEADACHE; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; ECOLOGY; ERYTHEMA NODOSUM; FUNGUS CULTURE; GASTRITIS; GEOGRAPHIC DISTRIBUTION; HABITAT; HUMAN; HYPERTHERMIC THERAPY; HYPERTHYROIDISM; IMMUNOASSAY; INCUBATION TIME; INFECTION RISK; LIVER TOXICITY; LYMPHATIC SYSTEM DISEASE; MINIMUM INHIBITORY CONCENTRATION; OPTIMAL DRUG DOSE; PHOTOSENSITIVITY; RECOMMENDED DRUG DOSE; RHINITIS; SEX RATIO; SKIN BIOPSY; SPOROTHRIX; SPOROTHRIX ALBICANS; SPOROTHRIX BRASILIENSIS; SPOROTHRIX GLOBOSA; SPOROTHRIX MEXICANA; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS; URTICARIA; ZOONOSIS;

EID: 78650743364     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. th edition. London: Hodder-Arnold; 2005. p. 367-84.
2. Marimon R, Cano J, Gené J, Sutton DA, Kawasaki M, Guarro J. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol 2007;45:3198-206.
3. Hay RJ, Morris-Jones R. Outbreaks of sporotrichosis. Curr Opin Infect Dis 2008,21:119-21.
4. Lavalle P, Mariat F. Sporotrichosis. Bull Inst Pasteur 1983;81:295-322.
5. Lopes-Bezerra LM, Schubach A, Costa RO. Sporothrix schenckii and sporotrichosis. An Acad Bras Cienc 2006;78:293-308.
6. Symmers WS. Sporotrichosis in Ireland. Ulster Med J 1968;37:85-101.
7. De Araujo T, Marques AC, Kerdel F. Sporotrichosis. Int J Dermatol 2001;40:737-42.
8. Kauffman CA. Sporotrichosis. Clin Infect Dis 1999;29:231-37.
9. rd edition. In: Micología médica básica. México DF: McGraw-Hill; 2010. p. 179-96.
10. González-Ochoa A, Soto-Figueroa E. Polisacáridos de Sporotrichum schenckii. Intradermorreacción en el diagnóstico de la esporotricosis. Rev Inst Salub Enferm Trop Mex 1947;8:143-53.
11. Mayorga J, Martínez LD, Méndez GA. Aislamiento de Sporothrix schenckii en la naturaleza (suelo y plantas). Med Cut ILA 1999;27:25-8.
12. Mayorga J, Tarango MV, Barba-Rubio J. Esporotricosis 100 años después. (1898-1998). Dermatología Rev Mex 1999;43:S22-9.
13. Espinoza-Texis A, Hernández-Hernández F, Lavalle P, Barba-Rubio J, López-Martínez R. Estudio de 50 pacientes con esporotricosis. Evaluación clínica y de laboratorio. Gac Med Méx 2001,137:111-6.
14. Marimon R, Serena C, Gené J, Cano J, Guarro J. In vitro antifungal susceptibilities of five species of Sporothrix. Antimicrob Agents Chemother 2008;52:732-4.
15. Marimon R, Gené J, Cano J, Guarro J. Sporothrix luriei:a rare fungus from clinical origin. Med Mycol 2008;46:621-5.
16. Schubach A, Barros MB, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis 2008;21:129-33.
17. Pappas PG, Tellez I, Deep AE, Nolasco D, Holgado W, Bustamante B. Sporotrichosis in Peru:description of an area of hyperendemicity. Clin Infect Dis 2000;30:65-70.
18. Bustamante B, Campos PE. Endemic sporotrichosis. Curr Opin Infect Dis. 2001;14:145-9.
19. Lyon GM, Zurita S, Casquero J, Holgado W, Guevara J, Brandt ME et al. Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru. Clin Infect Dis 2003;36:34-9. (Pubitemid 36099094)
20. Campos P, Arenas R, Coronado H. Epidemic cutaneous sporotrichosis. Int J Dermatol 1994;33:38-41.
21. Rubio G, Sánchez G, Porras L, Alvarado Z. Sporotrichosis: prevalence, clinical and epidemiological features in a reference center in Colombia. Rev Iberoam Micol 2010;27:75-9.
22. Barros MB, Costa DL, Schubach TM, do Valle AC, Lorenzi NP, Teixeira JL et al. Endemic of zoonotic sporotrichosis: profile of cases in children. Pediatr Infect Dis J 2008;3:246-50.
23. da Rosa AC, Scroferneker ML, Vettorato R, Gervini RL, Vettorato G, Weber A. Epidemiology of sporotrichosis: study of 304 cases in Brazil. J Am Acad Dermatol 2005;52:451-9.
24. de Oliveira MM, de Almeida-Paes R, de Medeiros Muniz M, de Lima Barros MB, Galhardo MC, Zancope-Oliveira RM. Sporotrichosis caused by Sporothrix globosa in Rio De Janeiro, Brazil: case report. Mycopathologia 2010;169:359-63.
25. Alencar-Marques S, Pires de Camargo RM, Haddad-Junior V. Human sporotrichosis: transmitted by feline. Ann Bras Dermatol 1998;73:559-62.
26. Freitas DF, do Valle AC, de Almeida Paes R, Bastos FI, Galhardo MC. Zoonotic Sporotrichosis in Rio de Janeiro, Brazil: a protracted epidemic yet to be curbed. Clin Infect Dis 2010;50:453.
27. Madrid IM, Mattei A, Martins A, Nobre M, Meireles M. Feline sporotrichosis in the southern region of rio grande do sul, Brazil: clinical, zoonotic and therapeutic aspects. Zoonoses Public Health 2010;57:151-4.
28. Schubach A, Schubach TM, Barros MB, Wanke B. Cat-transmitted sporotrichosis, Rio de Janeiro, Brazil. Emerg Infect Dis 2005;11:1952-4. (Pubitemid 43356098)
29. Dixon DM, Salkin IF, Duncan RA, Hurd NJ, Haines JH, Kemna ME et al. Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest U.S. epidemic of sporotrichosis. J Clin Microbiol 1991; 29:1106-13.
30. Barile F, Mastrolonardo M, Loconsole F, Rantuccio F. Cutaneous sporotrichosis in the period 1978-1992 in the province of Bari, Apulia, Southern Italy. Mycoses 1993;36:181-5.
31. Baroni A, Palla M, Iovene MR, Faccenda F, Aiello FS, Puca RV et al. Sporotrichosis: success of itraconazole treatment. Skinmed. 2007;6:41-4.
32. Criseo G, Malara G, Romeo O, Puglisi Guerra A. Lymphocutaneous sporotrichosis in an immunocompetent patients case report from extreme southern Italy. Mycopathologia 2008;166:159-62.
33. Cafarchia C, Sasanelli M, Lia RP, de Caprariis D, Guillot J, Otranto D. Lymphocutaneous and nasal sporotrichosis in a dog from southern Italy:case report. Mycopathologia 2007;163:75-9. (Pubitemid 46318711)
34. Alberici F, Paties CT, Lombardi G, Ajello L, Kaufman L, Chandler F. Sporothrix schenckii var luriei as the cause of sporotrichosis in Italy. Eur J Epidemiol 1989;5:173-7. (Pubitemid 19162203)
35. Magand F, Perrot JL, Cambazard F, Raberin MH, Labeille B. Autochthonous cutaneous sporotrichosis in France. Ann Dermatol Venereol 2009;136:273-5.
36. Ventin M, Ramirez C, Ribera M, Ferrandiz C, Savall R, Peyri J. A significant geographical area for the study of the epidemiological and ecological aspect of Mediterranean sporothricosis. Mycopathologia 1987;99:41-3.
37. Quintal D. Sporotrichosis infection on mines of the Witwatersrand. J Cut Med Surg 2000;4:51-4.
38. Yegneswaran PP, Sripathi H, Bairy I, Lonikar V, Rao R, Prabhu S. Zoonotic sporotrichosis of lymphocutaneous type in a man acquired from a domesticated feline source:report of a first case in southern Karnataka, India. Int J Dermatol 2009;48:1198-200.
39. Takenaka M, Sato S, Nishimoto K. Survey of 155 sporotrichosis cases examined in Nagasaki Prefecture from 1951 to 2007. Nippon Ishinkin Gakkai Zasshi 2009;50:101-8.
40. Inokuma D, Shibaki A, Shimizu H. Two cases of cutaneous sporotrichosis in continental/microthermal climate zone:global warming alert? Clin Exp Dermatol 2010;35:668-9
41. Itoh M, Okamoto S, Kariya H.Survey of 200 cases of sporotrichosis. Dermatologica 1986;172:209-13. (Pubitemid 16114428)
42. Mesa-Arango AC, Reyes-Montes R, Pérez-Mejia A, NavarroBarranco H, Souza V, Zúñiga G et al. Phenotyping and genotyping of Sporothrix schenckii isolates according to geographic origin and clinical form of Sporotrichosis. J Clin Microbiol 2002;40: 3004-11.
43. MacKinnon JE, Conti-Díaz IA. The effect of temperature on sporotrichosis. Sabouraudia 1962;2:56-9.
44. Hajjeh R, McDonnell S, Reef S, Licitra C, Hankins M, Toth B et al. Outbreak of sporotrichosis among tree nursery workers. J Infect Dis 1997;176:499-504.
45. Werner AH, Werner BE. Sporotrichosis in man and animal. Int J Dermatol 1994;33:692-700.
46. Berson SD, Brandt FA. Primary pulmonary sporotrichosis with unusual morphology. Thorax 1977;32:505-8.
47. Khabie N, Boyce TG, Roberts GD, Thompson DM. Laryngeal sporotrichosis causing stridor in a young child. Int J Pediatr Otorhinolaryngol 2003;67:819-23. (Pubitemid 36677551)
48. Hampton DE, Adesina A, Chodosh J. Conjunctival sporotrichosis in the absence of antecedent trauma. Cornea 2002;21:831-3. (Pubitemid 35239511)
49. Schubach A, de Lima Barros MB, Schubach TM, Francesconi-doValle AC, Gutierrez-Galhardo MC, Sued M et al. Primary conjunctival sporotrichosis:two cases from a zoonotic epidemic in Rio de Janeiro, Brazil. Cornea 2005;24:491-3.
50. Bonifaz A, Saúl A, Paredes-Solís V, Fierro L, Rosales A, Palacios C et al. Sporotrichosis in childhood. Clinical and therapeutic experience in 25 cases. Pediatr Dermatol 2007;24:369-72.
51. Pavón N, Bonifaz A, Ponce RM. Termoterapia em esporotricosis cutánea infantil. Comunicación de dos casos. Dermatologia Rev Mex 2007;51:68-72.
52. Tlougan BE, Podjasek JO, Patel SP, Nguyen XH, Hansen RC. Neonatal sporotrichosis. Pediatr Dermatol 2009;26:563-5.
53. Mariat F. Esporotricosis accidental adquirida en el laboratorio. Descripción de nuevos casos. Dermat Rev Mex 1981;25:361-90.
54. Madrid H, Cano J, Gené J, Bonifaz A, Toriello C, Guarro J. Sporothrix globosa, a pathogenic fungus with widespread geographical distribution. Rev Iberoam Micol 2009;26:218-22.
55. Ishizaki H, Kawasaki M, Aoki M, Wu S, Lin J, Kim JA et al. Mitocondrial DNA analysis of Sporothrix schenckii in North and South America. Mycopathologia 1998;142:115-8.
56. Ishizaki H, Kawasaki M, Aoki M, Wu S, Lin J, Kim JA et al. Mitochondrial DNA analysis of Sporothrix schenckii from China, Korea and Spain. Nippon Ishinkin Gakkai Zasshi 2004;45:23-5.
57. Kong X, Xiao T, Lin J, Wang Y, Chen HD. Relationships among genotypes, virulence and clinical forms of Sporothrix schenckii infection.Clin Microbiol Infect 2006;12:1077-81.
58. Reis RS, Almeida-Paes R, Muniz Mde M, Tavares PM, Monteiro PC, Schubach TM et al. Molecular characterisation of Sporothrix schenckii isolates from humans and cats involved in the sporotrichosis epidemic in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 2009; 104:769-74.
59. Travassos LR, Lloyd KO. Sporothrix schenckii and related species of Ceratocystis. Microbiol Rev 1980;44:683-721.
60. Beer ZW, Harrington TC, Vismer HF, Wingfield BD, Wingfield MJ. Phylogeny of the Ophiostoma stenoceras-Sporothrix schenckii complex. Mycologia 2003;95:434-41.
61. Teixeira PA, de Castro RA, Nascimento RC, Tronchin G, Torres AP, Lazéra M et al. Cell surface expression of adhesins for fibronectin correlates with virulence in Sporothrix schenckii. Microbiology 2009;155:3730-8.
62. Travassos LR, Mendoza PL. Syntesis of monorhamnosyl L-ramno-D-manosas by conidia of Sporothrix schenckii. Infect Inmun 1978;19:1107-9.
63. Figueiredo CC, De Lima OC, De Carvalho L, Lopes-Bezerra LM, Morandi V The in vitro interaction of Sporothrix schenckii with human endothelial cells is modulated by cytokines and involves endothelial surface molecules. Microb Pathog 2004;36:177-88.
64. Romero-Martinez R, Wheeler M, Guerrero-Plata A, Rico G, TorresGuerrero H. Biosynthesis and functions of melanin in Sporothrix schenckii. Infect Immun 2000;68:3696-703.
65. Morris-Jones R, Youngchim S, Gomez BL, Aisen P, Hay RJ, Nosanchuk JD et al. Synthesis of melanin-like pigments by Sporothrix schenckii in vitro and during mammalian infection. Infect Immun 2003;71:4026-33.
66. Madrid IM, Xavier MO, Mattei AS, Fernandes CG, Guim TN, Santin R et ai. Role of melanin in the pathogenesis of cutaneous sporotrichosis. Microbes Infect 2010;12:162-5.
67. Uenotsuchi T, Takeuchi S, Matsuda T, Urabe K, Koga T, Uchi H et al. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence. Int Immunol 2006;18:1637-46.
68. Sassá MF, Saturi AE, Souza LF, Ribeiro LC, Sgarbi DB, Carlos IZ. Response of macrophage Toll-like receptor 4 to a Sporothrix schenckii lipid extract during experimental sporotrichosis. Immunology 2009;128:301-9.
69. Barba-Borrego JA, Mayorga J, Tarango-Martínez VM. Simultaneous bilateral lymphangitic sporotrichosis. Rev iberoam Micol 2009;26:247-9.
70. Padilla-Desgarennes MC, Medina-Castillo DE, Cortés-Lozano N. Esporotricosis en edad pediátrica:experiencia del centro Dermatológico Pascua. Piel 2004; 19:350-63.
71. Bonifaz A, Vázquez-González D, Perusquía-Ortiz AM. Subcutaneous mycosesxhromoblastomycosis, sporotrichosis and mycetoma. J Dtsch Dermatol Ges 2010;8:619-28
72. Bonifaz A, Saúl A, Montes de Oca G, Mercadillo P. Superficial cutaneous sporotrichosis in specific anergic case. Int J Dermatol 1999;38:700-3. (Pubitemid 29468712)
73. Aronson EN. Disseminated sporotrichosis. JAMA 1992;268:2021.
74. Smith PW, Loomis WL, Luckasen JL, Osterholm RK. Disseminated cutaneous sporotrichosis. Arch Dermatol 1981; 117:143-4.
75. Bonifaz A, Peniche A, Mercadillo P, Saúl A. Successful treatment of AIDS-related disseminated cutaneous sporotrichosis with itraconazole. AIDS patient AIDS 2001, 15:603-6.
76. Ware AJ, Cockerell CJ, Skiest DJ, Kussman HM. Disseminated sporotrichosis with extensive cutaneous involment in a patient with AIDS. J Am Acad Dermatol 1999;40:350-5.
77. Shaw JC, Levinson W, Montanaro A. Sporotrichosis in the immunodeficiency syndrome. J Am Acad Dermatol 1989;21:1145-7.
78. Galhardo MC, Silva MT, Lima MA, Nunes EP, Schettini LE, de Freitas RF et al. Sporothrix schenckii meningitis in AIDS during immune reconstitution syndrome. J Neurol Neurosurg Psychiatry 2010;81:696-9.
79. Gutierrez-Galhardo MC, do Valle AC, Fraga BL, Schubach AO, Hoagland BR, Monteiro PC et al. Disseminated sporotrichosis as a manifestation of immune reconstitution inflammatory syndrome. Mycoses 2010;53:78-80.
80. Kosinski RM, Axelrod P, Rex JH, Burday M, Sivaprasad R, Wreiole A. Sporothrix schenckii fungemia without disseminated sporotrichosis. J Clin Microbiol 1992;30:501-3.
81. Yelverton CB, Stetson CL, Bang RH, Clark JW, Butler DF. Fatal sporotrichosis. Cutis 2006;78:253-6.
82. Sánchez-Alemán MA, Araiza J, Bonifaz A. Aislamiento y caracterización de cepas silvestres de Sporothrix schenckii e investigación de reactores a la esporotricina. Gac Med Mex 2004;140:507-12.
83. Kashima T, Honma R, Kishi S, Hirato J. Bulbar conjunctival sporotrichosis presenting as a salmon-pink tumor. Cornea 2010;29:573-6.
84. Orofino-Costa R, Bóia MN, Magalhães GA, Damasco PS, Bernardes-Engemann AR, Benvenuto F et al. Arthritis as a hypersensitivity reaction in a case of sporotrichosis transmitted by a sick cat:clinical and serological follow up of 13 months. Mycoses 2010;53:81-3.
85. Mahajan VK, Sharma NL, Shanker V, Gupta P, Mardi K. Cutaneous sporotrichosis:unusual clinical presentations. Indian J Dermatol Venereol Leprol 2010;76:276-80.
86. Hu S, Chung WH, Hung SI. Detection of Sporothrix schenckii in clinical samples by a nested PCR assay. J Clin Microbiol 2003;41:1414-8.
87. Novales SJ, Navarrete FG, Ramos GA. Esporotricosis. Aspectos histológicos de 50 casos. Rev Centr Dermatol Pascua 1995;4:149-52.
88. Saúl A. Sporotrichosis. In: Antifungal Drug Therapy. Edit Jacobs PH Nail L Marcel Dekker Inc New York 1990. p. 53-9.
89. Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. Clin Infect Dis 2000;30:684-7.
90. Bustamante B, Campos PE. Sporotrichosiss forgotten disease in the drug research agenda. Expert Rev Anti Infect Ther 2004;2:85-94.
91. Torres-Mendoza B, Vázquez-Vails E, González-Mendoza A. Efecto del yoduro de potasio sobre la respuesta inmune en la esporotricosis. Rev Iberoam Micol 1997;14:98-100. (Pubitemid 127525786)
92. Xiao T, Lin J, Chen HD. Prominent facial edema caused by potassium iodide solution in a patient with sporotrichosis. J Dermatol 2009;36:111-3.
93. Xue SL, Li L. Oral potassium iodide for the treatment of sporotrichosis. Mycopathologia 2009;167:355-6.
94. Cullen S. Maucer AA, Warner N. Successful treatment of disseminated cutaneous sporotrichosis with ketoconazole. J Am Acad Dermatol 1992;27:463-4.
95. Antunes Tde A, Nobre Mde O, Faria RO, Meinerz AR, Martins AA, Cleff MB et al. Experimental cutaneous sporotrichosis:in vivo evaluation of itraconazole and terbinafine. Rev Soc Bras Med Trop 2009;42:706-10.
96. Sharkey-Mahis PK, Kauffman CA, Graybill JR, Stevens DA, Hostetler JS, Cloud G et al. Treatment of sporotrichosis with itraconazole. Am J Med 1993;95:279-85.
97. Bonifaz A, Fierro L, Saúl A, Ponce RM. Cutaneous sporotrichosis. Intermittent treatment (pulses) with itraconazole. Eur J Dermatol 2007;18:61-4. (Pubitemid 351158174)
98. Castro LG, Belda W, Cucé LC, Sampaio SA, Stevens DA. Successful treatment of sporotrichosis with oral fluconazoles report of three cases. Br J Dermatol 1993;128:352-6.
99. Francesconi G, Valle AC, Passos S, Reis R, Galhardo MC. Terbinafine (250 mg/day):an effective and safe treatment of cutaneous sporotrichosis. J Eur Acad Dermatol Venereol 2009;23:1273-6.
100. Badgwell Doherty C, Doherty SD, Rosen T. Thermotherapy in dermatologic infections. J Am Acad Dermatol 2010;62:909-27.